Sign In
Buy ADMA
$8.69
+0.120 (+1.40%)
At Close: Jun 23, 2026
Berger Montague PC Investigating Claims on Behalf of ADMA Biologics, Inc. (NASDAQ: ADMA) Investors After Class Action Filing
08:44am, Thursday, 18'th Jun 2026
PHILADELPHIA, June 18, 2026 (GLOBE NEWSWIRE) -- National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Comp
Grabar Law Office Investigates ADMA Biologics, Inc. (ADMA) on Behalf of Long-Term Shareholders
08:16am, Thursday, 18'th Jun 2026
Philadelphia, Pennsylvania--(Newsfile Corp. - June 18, 2026) - Grabar Law Office is investigating whether certain officers and directors of ADMA Biologics, Inc. (NASDAQ: ADMA) breached their fiduciary
Faruqi and Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In ADMA Biologics To Contact
Adma Biologics (ADMA) Dips More Than Broader Market: What You Should Know
06:50pm, Wednesday, 17'th Jun 2026
The latest trading day saw Adma Biologics (ADMA) settling at $8.42, representing a -1.86% change from its previous close.
New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 17, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies i
Did you buy ADMA securities between August 9, 2024 and March 25, 2026 ? Affected ADMA Investor Summary Who: ADMA Biologics, Inc. (NASDAQ: ADMA) What: Securities fraud class action lawsuit filed Class
ADMA DEADLINE: Levi & Korsinsky Reminds ADMA BIOLOGICS, INC. Investors of Upcoming Securities Class Action Deadline
10:13am, Wednesday, 17'th Jun 2026
ADMA Biologics allegedly certified internal controls as effective while concealing channel stuffing and an undisclosed related party distributor operating from company headquarters. NEW YORK, June 17,
Portnoy Law Firm Announces Class Action on Behalf of ADMA Biologics, Inc. Investors
10:05am, Wednesday, 17'th Jun 2026
LOS ANGELES, June 17, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises ADMA Biologics, Inc., (“ADMA” or the "Company") (NASDAQ: ADMA) investors of a class action on behalf of investors that
NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against ADMA Biologics, Inc. (NASDAQ:ADMA) and
ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
06:14pm, Tuesday, 16'th Jun 2026
NEW YORK, June 16, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of ADMA Biologics,
SAN DIEGO, June 16, 2026 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of ADMA Biologics, Inc. (NASDAQ: ADMA) publicly traded securities between August 9,
RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class
NEW YORK, June 16, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against ADMA Biologics, Inc. (“ADMA” or the “Company”) (NASDAQ: ADMA). Such inves
New York, New York and New Orleans, Louisiana--(Newsfile Corp. - June 16, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies i
[url="]Glancy Prongay Wolke and Rotter LLP[/url] reminds investors of the upcoming August 10, 2026 deadline to file a lead plaintiff motion in the class action fi
